One of the world’s most deadly diseases, tuberculosis, primarily a lung disease, infects more than 8 million people and is responsible for 1.5 million deaths each year. According to the … Continue Reading Previously unknown method of tuberculosis infection identified.
The WHO recommends complete withdrawal of the oral polio vaccine (OPV) by April 2016 globally and replacing with at least one dose of inactivated poliovirus vaccine (IPV). However, high-cost, limited … Continue Reading Researchers develop plant-based Polio booster vaccine.
The human immunodeficiency virus (HIV) is a lentivirus which causes HIV infection and over time AIDS. Developing effective prevention measures for HIV is hindered by incomplete knowledge of the phenotype … Continue Reading New technology lights up location of first cells to be infected in female HIV transmission.
Nanovaccine successfully protects against primary and secondary female genital herpes infections in animals.
Herpes simplex virus-2, which causes serious eye infections in newborns and immunocompromised patients as well as genital herpes, is one of the most common human viruses. According to the Centers … Continue Reading Nanovaccine successfully protects against primary and secondary female genital herpes infections in animals.
Type 1 diabetes is an autoimmune disease, meaning that the underlying problem is with the immune system. It is still unclear as to why the body’s immune system attacks and … Continue Reading Salmonella-based oral vaccine for T1 diabetes successful in animal model.
Envelope glycoprotein GP120 is a glycoprotein exposed on the surface of the HIV envelope (ENV). The envelope glycoprotein trimer is essential for HIV entry into cells as it plays a … Continue Reading New breakthrough imaging shows HIV structure in unprecedented detail.
In recent years, Ebola outbreaks have increased in frequency, duration, and geographical spread, underscoring the need for pre- and post-exposure treatments. Antibodies targeting the Ebola virus surface glycoprotein, the viral structure … Continue Reading Previously unknown ebola-fighting antibodies identified in outbreak survivor’s blood.
MERS is caused by an emerging human coronavirus, which is distinct from the SARS coronavirus. Since its identification in 2012, MERS has been linked to over 1,300 infections and close … Continue Reading New synthetic-DNA vaccine protects against MERS in simian model.
A collaborative team from The University of Texas and the National Institutes of Health have developed an inhalable vaccine that successfully protects primates against Ebola in simian trials. The team … Continue Reading First ever inhalable ebola vaccine is successful in simian trials.
New technology developed by Howard Hughes Medical Institute (HHMI) and Brigham and Women’s Hospital researchers makes it possible to test for current and past infections with any known human virus by … Continue Reading New bacteriophage-based assay gives a person’s whole viral infection history in a drop of blood.
In a study that included approximately 95,000 children with older siblings it has been shown that receipt of the measles-mumps-rubella (MMR) vaccine was not associated with an increased risk of … Continue Reading Large-scale study finds no link between MMR vaccine and autism, even among children at higher risk.
Researchers from the Garvan Institute of Medical Research have discovered a new population of ‘memory’ immune cells, throwing light on what the body does when it sees a microbe for the … Continue Reading Researchers discover a new type of ‘memory’ immune cell.
Antibodies from dromedary camels protected uninfected mice from Middle East Respiratory Syndrome (MERS), and helped infected mice expunge the disease, according to an opensource study in the Journal of Virology. … Continue Reading Using camel antibodies to protect humans from MERS, POC study successful.
In the ongoing Ebola outbreak in West Africa, whose death toll is approaching 10,000, little information has been available about how the human immune response unfolds after infection. Now, researchers … Continue Reading First look at hospitalized Ebola survivors’ immune cells finds no immunosuppression.
When a promising nicotine vaccine failed in clinical trials a few years ago, scientists from The Scripps Research Institute (TSRI) were determined to keep trying to help smokers overcome their … Continue Reading Scientists design a nicotine vaccine which provokes a robust immune response.
A 12-year study of two measles-containing vaccines found that seven main adverse outcomes were unlikely after either vaccine. The study, conducted by the Kaiser Permanente Vaccine Study Center, included children … Continue Reading 12-year study confirms overall safety of measles vaccines.